Do you have #HER2positive#BreastCancer? If so, you may be eligible to participate in the phase 2 #ClinicalTrial EA1211/DIRECT, testing if FDG-PET/CT imaging can better predict a patient's response to treatment than the usual approach. Learn more: https://t.co/JdsOLY3ZpA
Knowing your breast density is important because it can affect your risks for breast cancer and how you should be screened. Learn more in an expert-led webinar: https://t.co/KmebxYLskK
A new imaging agent, ⁶⁸Ga-ABY-025, can predict early metabolic response to HER2-targeted treatment in HER2-positive metastatic #BreastCancer patients, according to new research published in JNM. https://t.co/jLVO2xbFk1
#NuclearMedicine#MedicalImaging@JournalofNucMed
Our own #RIMIRad, Dr. Dibble, was featured on the @SBC_org Podcast, where she talks about the latest advancements in breast imaging and the importance of early detection. Click here to listen to the entire podcast: https://t.co/y76hhEO4Jc
📄 In Press @JACRJournal
"Given the current wide-open job market for radiologists...(&) the 2022 passage of paid family & medical leave policies by the ACR & AMA... practice leaders making hiring decisions may benefit from familiarity with the latter..."
https://t.co/ScqPW8kqe3
Can boosting familiarity with the Family Medical Leave Act ease the labor shortage many U.S. radiology practices face?
Associate Professor of Diagnostic Imaging @edibbleMD says it could.
Read more about this Brown-led study:
https://t.co/OdsEf7y1co
Excellent study on human-AI interaction published in @EurRadiology (also highlighted in the recent @TheImagingWire)!! 👇
More evidence that we need to be careful with #AI in #radiology!
https://t.co/rkG2RmhSAF
What happens when AI is wrong? 👀 the latest publication from the Brown Radiology Human Factors Lab @MichaelAtalay @DoctorAWPM https://t.co/ZPvShgDoCy
Brilliant study of PET-FDG vs conventional staging for stage IIB-III early breast cancer by the Canadian colleagues. PET doubled the diagnoses of metastatic disease & prevented unnecessary intensive treatment in ~20% of the pts. Adequate staging is key! https://t.co/RapIbQEYTR
Thank you @RadiologyBiz for highlighting the importance of #rads standing up for patients! Reference Committee Open Hearings tomorrow from 1:30-5 ET. #Rads4Choice#Resolution11 🎉https://t.co/SL18MDYt5m